Bnp Paribas Bristol Myers Squibb CO Transaction History
Bnp Paribas
- $3.02 Billion
- Q2 2025
A detailed history of Bnp Paribas transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bnp Paribas holds 63,118 shares of BMY stock, worth $2.91 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
63,118
Previous 40,856
54.49%
Holding current value
$2.91 Million
Previous $2.49 Million
17.26%
% of portfolio
0.1%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.98 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.31 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.98 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...